ClariVest Asset Management’s Enanta Pharmaceuticals ENTA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-37,839
| Closed | -$2.27M | – | 667 |
|
|
2019
Q3 | $2.27M | Sell |
37,839
-15,100
| -29% | -$907K | 0.05% | 241 |
|
|
2019
Q2 | $4.47M | Buy |
52,939
+21,096
| +66% | +$1.78M | 0.1% | 173 |
|
|
2019
Q1 | $3.04M | Sell |
31,843
-2,434
| -7% | -$232K | 0.06% | 251 |
|
|
2018
Q4 | $2.43M | Buy |
34,277
+13,235
| +63% | +$937K | 0.05% | 270 |
|
|
2018
Q3 | $1.8M | Sell |
21,042
-619
| -3% | -$52.9K | 0.03% | 335 |
|
|
2018
Q2 | $2.51M | Buy |
21,661
+10,761
| +99% | +$1.25M | 0.04% | 310 |
|
|
2018
Q1 | $882K | Sell |
10,900
-4,300
| -28% | -$348K | 0.02% | 442 |
|
|
2017
Q4 | $892K | Buy |
15,200
+1,700
| +13% | +$99.8K | 0.02% | 434 |
|
|
2017
Q3 | $631K | Buy |
13,500
+100
| +0.7% | +$4.67K | 0.01% | 369 |
|
|
2017
Q2 | $482K | Hold |
13,400
| – | – | 0.01% | 388 |
|
|
2017
Q1 | $413K | Buy |
13,400
+100
| +0.8% | +$3.08K | 0.01% | 408 |
|
|
2016
Q4 | $446K | Buy |
+13,300
| New | +$446K | 0.01% | 409 |
|